As research becomes increasingly interdisciplinary and the lines between academic and industrial pursuits blur, scientists on both sides of the fence are developing outsourcing models to build innovative collaborations and open funding opportunities.
When Hurricane Katrina hit the Gulf Coast, newly minted Tulane University assistant professor Thomas Voss suddenly found himself without a home, without a lab, without even his university e-mail account. Voss had just moved to Tulane from Southern Research, a contract research organization (CRO) commonly hired by pharmaceutical and biotech companies to complete specific portions of research projects that the client cannot handle internally. In the face of the natural disaster, Voss returned to what he knew.
He set out with his family for 6 months as what he calls a ''lab on the road.'' He teamed up with researchers that he knew from his time at Southern Research on various projects related to his background in viral therapeutics. For instance, he set up in vitro screens for treatments under development and taught researchers how to harvest mouse lungs for virology in vivo studies. Now, 7 years later, he has recovered his lab space and secured grant funding-he later found out that he had secured an NIH grant the day of the hurricane, but the letter was lost in the mail in the storm's aftermath -but he also maintains the relationships that he built in those post-Katrina months. As a result, his lab is an unorthodox but successful hybrid: he spends the majority of his time conducting traditional grant-funded basic research, but he also offers his expertise as a fee-for-service contract researcher for both academic and industrial clients.
This arrangement offers access to a large potential funding base that most of his academic colleagues do not tap into, which offers a huge advantage given the competition for grant money.
''In academics, the interest is always in getting NIH grants, but the truth is, a lot of the money-as science is changing-is not in grants,'' Voss says. ''The money is in different places now than it used to be.'' But it's not just about the money. Voss is genuinely enthusiastic about the science behind his contract projects and the directions it can take his work. For example, with his industrial clients, he says, ''we get to do really great work for companies that have a product that needs to be developed, and we get to do the basic research around it.'' His contract work is also quite varied. He has relatively small, focused projects but also long-term relationships with clients that involve major intellectual contributions from both partners.
Client or Collaborator?
These larger projects challenge the boundary between a contractor and a true collaborator. ''It's almost impossible to think of it in any other way than a collaboration,'' says Pat Iversen, a senior vice president at AVI BioPharma and one of Voss's clients, who has worked with him since he began at Tulane.
Rather than a strictly business arrangement, these flexible interactions between academic and industrial scientists allow researchers to come together in new, more efficient ways. Both sides can often reach a solution more quickly and probably gain greater insight than if they had each tried to go it alone.
These types of contract-collaboration relationships are likely to become more common as some academic and industrial research goals begin to converge.
''Today in academia, there's a large push to do more industrial-type research,'' says Emilio Esposito, founder of a computational chemistry and biochemistry consultancy called exeResearch. ''Bringing someone in helps everyone because it gets the work moving. '' Esposito believes that the rising interdisciplinary nature of modern science may be driving an increase in consulting and outsourcing. This trend is already apparent in commercial research. In a 2011 poll of members of BayBio, a nonprofit association for biosciences in Northern California, 67% of respondents from pharmaceutical and life science companies reported that they expect their outsourcing needs to increase in the future.
This trend may also be expanding beyond the traditional industry-CRO relationship and affect academic research, as suggested by the rise of online services like Science Exchange and Zombal, scientific ''marketplaces'' intended to allow scientists to find external researchers to conduct specific experiments. These web sites are friendly to academic and commercial researchers alike, which may help open the door for academics to find the expertise and rapid results they need from outside the academy, rather than from the professor in the office next door.
And outsourcing does not have to mean completely ceding control of the project or giving up the opportunity for further intellectual involvement and development. For Esposito, a crucial part of his job is education. When he's working on a project for a lab, he says, ''I don't just do the work-I also teach the student what's going on so they don't need me for the next project.'' Like Voss, Esposito challenges conventional expectations about the relationship between researchers and paid outsourcers.
''There's a distinction between what people see as a consultant versus a collaborator,'' Esposito says. ''A consultant is someone they just hand the work over to and then take the results from. A collaborator is someone they work with more closely.'' How does he view his role? ''I definitely see myself as more of a collaborator,'' he says.
New Funding, New Frontiers Sometimes, though, researchers don't actually want a collaborator, even if they don't know it.
When the Dana-Farber Cancer Institute in Boston identified a gap in their bioinformatics expertise, their first thought was to hire several professors in the area, including John Quackenbush, a professor of computational biology and bioinformatics, who quickly pointed out the flaw in their strategy.
''Biologists now are drowning in data, and computational biologists want to analyze the data,'' Quackenbush asserts. ''But computational biologists don't want to do it for you [the biologists]-they want to do it for themselves.'' His colleagues, he felt, were ''asking us to do service, not science.'' The analogy, he says, would be if he asked them to run thousands of PCRs for him. Though that could be a very valuable service and requires a specific skill set, it is not a collaboration.
Instead of investing in more faculty who would be interested in building collaborations, but not providing services, he proposed that Dana-Farber set up a core facility to provide the needed services. The result is the Center for Cancer Computational Biology (CCCB), equipped with researchers from technicians to experienced scientists who provide expert fee-for-service bioinformatic analysis, as well as assistance with experimental design and data collection as needed.
Quackenbush spends about 10% of his time running the center, which is embedded in his research group but has its own dedicated staff. This hybrid setup means that clients get their results quickly (as opposed to requests for collaboration, which can end up on the shelf for months or years), the CCCB scientists benefit from the expertise of Quackenbush's lab, and Quackenbush can pursue his research while also helping his academic colleagues.
''It allows me to focus on the research questions that motivate me and has allowed me to come up with a good compromise to meet the needs of the people here without sacrificing my own career,'' Quackenbush said.
It seems to be working for the clients as well. The center completed $850,000 worth of business in 2011 and is rapidly growing to include clients in Seattle, Canada, and Russia.
The original proposal for the center suggested that it should be funded by grant money, an approach that Quackenbush says was ''doomed to fail.'' Aside from the huge amount of time he would have had to spend just writing grants, he also felt that it was important for researchers to have a financial investment in the process to improve the efficiency and ultimately accelerate the research.
''If something is free, people don't value it,'' Quackenbush said. ''If they're not paying for it, it's a never-ending process of failures and trying again.'' Paying for the CCCB's work, on the other hand, ultimately serves both the researcher and the center.
And in many cases, the CCCB scientists get involved in projects beyond simply providing a service, to the extent that, in some cases, it is appropriate for them to share authorship on papers, again blurring the line between contractor and collaborator.
For CCCB, as well as Voss and Esposito, it's really about finding a way to get the research performed well, regardless of labels or the norms by which research has traditionally been conducted. Their innovative blends of academic and industrial, and collaborator and contractor, provide appealing examples for reevaluating how research can best be completed and the good that can come from looking for creative solutions to ever-changing challenges.
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